Evidence map›Paper›PMID 27480076›Full record

ArticleBMC biology2016

MAPK signaling is necessary for neurogenesis in Nematostella vectensis.

Michael J Layden, Hereroa Johnston, Aldine R Amiel, Jamie Havrilak, Bailey Steinworth, Taylor Chock, Eric Röttinger, Mark Q Martindale

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Cells · 2021
    Review
  15. Article
  16. Ectopic activation of GABANature ecology & evolution · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Michael J LaydenDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, USA. layden@lehigh.edu.
Hereroa JohnstonUniversité Nice Sophia Antipolis UMR 7284, CNRS UMR 7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice, France.
Aldine R AmielUniversité Nice Sophia Antipolis UMR 7284, CNRS UMR 7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice, France.
Jamie HavrilakDepartment of Biological Sciences, Lehigh University, Bethlehem, PA, USA.
Bailey SteinworthThe Whitney Marine Laboratory for Marine Science, University of Florida, St. Augustine, Florida, USA.
Taylor ChockThe Whitney Marine Laboratory for Marine Science, University of Florida, St. Augustine, Florida, USA.
Eric RöttingerUniversité Nice Sophia Antipolis UMR 7284, CNRS UMR 7284, INSERM U1081, Institute for Research on Cancer and Aging, Nice, France.
Mark Q MartindaleThe Whitney Marine Laboratory for Marine Science, University of Florida, St. Augustine, Florida, USA. mqmartin@whitney.ufl.edu.
Centre National de la Recherche Scientifique · FRLehigh University · USUniversity of Florida · USInstitut de Recherche sur le Cancer et le Vieillissement de Nice · FRWhitney Museum of American Art · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe nerve net of Nematostella is generated using a conserved cascade of neurogenic transcription factors. For example, NvashA, a homolog of the achaete-scute family of basic helix-loop-helix transcription factors, is necessary and sufficient to specify a subset of embryonic neurons. However, positive regulators required for the expression of neurogenic transcription factors remain poorly understood.

resultsWe show that treatment with the MEK/MAPK inhibitor U0126 severely reduces the expression of known neurogenic genes, Nvath-like, NvsoxB(2), and NvashA, and known markers of differentiated neurons, suggesting that MAPK signaling is necessary for neural development. Interestingly, ectopic NvashA fails to rescue the expression of neural markers in U0126-treated animals. Double fluorescence in situ hybridization and transgenic analysis confirmed that NvashA targets represent both unique and overlapping populations of neurons. Finally, we used a genome-wide microarray to identify additional patterning genes downstream of MAPK that might contribute to neurogenesis. We identified 18 likely neural transcription factors, and surprisingly identified ~40 signaling genes and transcription factors that are expressed in either the aboral domain or animal pole that gives rise to the endomesoderm at late blastula stages.

conclusionsTogether, our data suggest that MAPK is a key early regulator of neurogenesis, and that it is likely required at multiple steps. Initially, MAPK promotes neurogenesis by positively regulating expression of NvsoxB(2), Nvath-like, and NvashA. However, we also found that MAPK is necessary for the activity of the neurogenic transcription factor NvashA. Our forward molecular approach provided insight about the mechanisms of embryonic neurogenesis. For instance, NvashA suppression of Nvath-like suggests that inhibition of progenitor identity is an active process in newly born neurons, and we show that downstream targets of NvashA reflect multiple neural subtypes rather than a uniform neural fate. Lastly, analysis of the MAPK targets in the early embryo suggests that MAPK signaling is critical not only to neurogenesis, but also endomesoderm formation and aboral patterning.

Indexed as

MAP Kinase Signaling SystemNeurogenesisAnimalsButadienesCnidariaDown-RegulationEctodermEmbryo, NonmammalianExtracellular Signal-Regulated MAP KinasesGastrulationGene Expression Regulation, DevelopmentalMitogen-Activated Protein Kinase KinasesModels, BiologicalNeuronsNitrilesPhosphorylationButadienesExtracellular Signal-Regulated MAP KinasesMitogen-Activated Protein Kinase KinasesNitrilesU 0126

Identifiers

PMID27480076
PMCPMC4968017
OpenAlexW2503883440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.